title: No acquisition: a new ambition for HIV vaccine development?
abstract: Development of a safe and effective prophylactic HIV-1 vaccine presents unique challenges. The pessimism following the failure of two HIV-1 vaccine concepts in clinical trials, HIV-1 gp120 and an adenovirus-based approach to induce only cellular immune responses, has been replaced by cautious optimism engendered by the RV144 trial outcome, the isolation of several new broadly reactive neutralizing monoclonal antibodies, and recent primate model data indicating prevention of viral acquisition by active or passive immunization. Intense efforts are underway to optimize immunogen design, adjuvants, and the tools for preclinical evaluation of candidate vaccines in primates, where correlates of protection can be examined in detail - as proof-of-concept for clinical trials.
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA 02115, USA.
authors.forename: Samir K
authors.initials: SK
authors.lastname: Lakhashe
authors.forename: Guido
authors.initials: G
authors.lastname: Silvestri
authors.forename: Ruth M
authors.initials: RM
authors.lastname: Ruprecht
mesh_terms: D016915:AIDS Vaccines / Q000235:genetics / Q000276:immunology*; D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans
chemical_list: D016915:AIDS Vaccines
references.citation: PLoS One. 2011 Mar 31;6(3):e18207
references.pmid: 21483815
references.citation: Immunity. 2011 Feb 25;34(2):269-80
references.pmid: 21315623
references.citation: PLoS One. 2011;6(7):e22010
references.pmid: 21799765
references.citation: J Virol. 2005 Dec;79(24):15547-55
references.pmid: 16306625
references.citation: J Virol. 2010 Jul;84(14):7161-73
references.pmid: 20444898
references.citation: J Infect Dis. 2011 Jul 1;204(1):164-73
references.pmid: 21628671
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):6-18
references.pmid: 9732063
references.citation: AIDS. 2007 Sep 12;21(14):1841-8
references.pmid: 17721091
references.citation: J Med Primatol. 1999 Aug-Oct;28(4-5):164-8
references.pmid: 10593481
references.citation: Vet Parasitol. 2007 Aug 19;148(1):14-20
references.pmid: 17587500
references.citation: Vaccine. 2011 Aug 5;29(34):5611-22
references.pmid: 21693155
references.citation: Curr Opin HIV AIDS. 2009 Sep;4(5):388-93
references.pmid: 20048702
references.citation: J Gen Virol. 1998 Oct;79 ( Pt 10):2461-7
references.pmid: 9780052
references.citation: Immunity. 2010 Oct 29;33(4):504-15
references.pmid: 21029961
references.citation: Immunobiology. 2007;212(6):475-90
references.pmid: 17544832
references.citation: Nature. 2009 Jan 1;457(7225):87-91
references.pmid: 18997770
references.citation: Nat Med. 2009 Mar;15(3):293-9
references.pmid: 19219024
references.citation: Nature. 2011 May 26;473(7348):523-7
references.pmid: 21562493
references.citation: J Virol. 2009 Jul;83(13):6508-21
references.pmid: 19403685
references.citation: PLoS One. 2010 Jul 21;5(7):e11689
references.pmid: 20657739
references.citation: J Virol. 2007 Nov;81(22):12368-74
references.pmid: 17686853
references.citation: Science. 1996 Jun 7;272(5267):1486-9
references.pmid: 8633242
references.citation: J Infect Dis. 2010 Apr 15;201(8):1155-63
references.pmid: 20214475
references.citation: PLoS Negl Trop Dis. 2008 Jul 23;2(7):e265
references.pmid: 18648516
references.citation: Nature. 2009 Apr 2;458(7238):636-40
references.pmid: 19287373
references.citation: Mol Ther. 2011 Feb;19(2):417-26
references.pmid: 21081905
references.citation: Curr HIV Res. 2007 Nov;5(6):642-55
references.pmid: 18045119
references.citation: J Infect Dis. 2011 Apr 1;203(7):969-75
references.pmid: 21402548
references.citation: Vaccine. 1992;10(12):873-9
references.pmid: 1455913
references.citation: Nat Rev Immunol. 2009 Oct;9(10):717-28
references.pmid: 19859066
references.citation: Nat Med. 2010 Oct;16(10):1117-9
references.pmid: 20890292
references.citation: J Virol. 2009 Feb;83(3):1422-32
references.pmid: 19019970
references.citation: J Mol Biol. 2011 Jan 7;405(1):284-97
references.pmid: 20969873
references.citation: Immunity. 2007 Sep;27(3):406-16
references.pmid: 17892849
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15831-6
references.pmid: 19717425
references.citation: Science. 2009 Oct 9;326(5950):285-9
references.pmid: 19729618
references.citation: J Virol. 2001 Jun;75(11):5151-8
references.pmid: 11333896
references.citation: Virology. 2001 Jan 5;279(1):241-56
references.pmid: 11145906
references.citation: J Virol. 2005 Oct;79(19):12321-31
references.pmid: 16160159
references.citation: Nat Med. 2002 Mar;8(3):207-10
references.pmid: 11875482
references.citation: J Virol. 2001 Feb;75(4):1990-5
references.pmid: 11160699
references.citation: Adv Pharmacol. 2008;56:369-98
references.pmid: 18086418
references.citation: N Engl J Med. 2009 Dec 3;361(23):2209-20
references.pmid: 19843557
references.citation: J Virol. 2006 Jun;80(12):5875-85
references.pmid: 16731926
references.citation: J Infect Dis. 2005 Mar 1;191(5):654-65
references.pmid: 15688278
references.citation: Sci Transl Med. 2011 May 4;3(81):81ra36
references.pmid: 21543722
references.citation: Vaccine. 2007 Nov 19;25(47):8021-35
references.pmid: 17935840
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12324-9
references.pmid: 15297611
references.citation: Nature. 2007 Sep 6;449(7158):101-4
references.pmid: 17805298
references.citation: J Virol. 2007 Jun;81(11):5594-606
references.pmid: 17376901
references.citation: J Infect Dis. 2001 Dec 15;184(12):1603-7
references.pmid: 11740737
references.citation: Lancet. 2008 Nov 29;372(9653):1881-1893
references.pmid: 19012954
references.citation: Nature. 1991 Oct 3;353(6343):393
references.pmid: 1815549
references.citation: Nat Med. 2007 Jan;13(1):100-6
references.pmid: 17187074
references.citation: PLoS One. 2010 Jan 20;5(1):e8805
references.pmid: 20098712
references.citation: J Infect Dis. 2006 Dec 15;194(12):1661-71
references.pmid: 17109337
references.citation: J Virol. 2004 Jun;78(11):5983-95
references.pmid: 15140996
references.citation: Expert Opin Biol Ther. 2009 Jan;9(1):55-69
references.pmid: 19063693
references.citation: Immunity. 2010 Oct 29;33(4):492-503
references.pmid: 21029960
references.citation: Science. 1992 Jan 17;255(5042):292-3
references.pmid: 1549775
references.citation: PLoS Negl Trop Dis. 2011 Aug;5(8):e1270
references.pmid: 21829749
references.citation: Nat Med. 2011 Mar;17(3):366-71
references.pmid: 21358627
references.citation: Semin Immunol. 1998 Jun;10(3):215-23
references.pmid: 9653048
references.citation: Retrovirology. 2007 Sep 21;4:65
references.pmid: 17888148
references.citation: J Biol Chem. 2011 Jun 24;286(25):22250-61
references.pmid: 21515681
references.citation: J Virol. 2011 Jul;85(13):6442-52
references.pmid: 21490092
references.citation: Immunity. 2010 Oct 29;33(4):542-54
references.pmid: 21029964
references.citation: Science. 1993 Dec 17;262(5141):1820-1
references.pmid: 8266069
references.citation: AIDS. 2006 Nov 14;20(17):2135-40
references.pmid: 17086052
references.citation: Nat Med. 2008 Jun;14(6):617-21
references.pmid: 18535579
references.citation: J Virol. 2010 Mar;84(6):2996-3003
references.pmid: 20042509
references.citation: J Virol. 2006 Sep;80(17):8729-38
references.pmid: 16912320
references.citation: Science. 2010 Aug 13;329(5993):856-61
references.pmid: 20616233
references.citation: Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
references.pmid: 1595015
references.citation: J Immunol. 2009 Mar 15;182(6):3718-27
references.pmid: 19265150